Search - tctmd.com

Displaying 81 - 100 of 767

Sort: Relevancy | Date

News Daily News

Study Links Osteoporosis Injections and Increased MACE in Dialysis Patients

L.A. McKeown

January 06, 2025

News Daily News

Top Structural Heart News of 2024

L.A. McKeown

December 29, 2024

News Daily News

Top Endovascular News of 2024

L.A. McKeown

December 28, 2024

News Daily News

Tirzepatide Gets FDA Approval for Sleep Apnea in Adults With Obesity

L.A. McKeown

December 23, 2024

News Opinion CV Team Dispatch

December 2024 Dispatch for the CV Team

L.A. McKeown

December 20, 2024

News Daily News

Obesity Trends May Be Going in the Right Direction for the First Time in a Decade

L.A. McKeown

December 18, 2024

News Daily News

FINEARTS-HF Analysis Supports Finerenone’s Value in HFpEF With Obesity

L.A. McKeown

December 13, 2024

News Daily News

As More Peripheral Interventions Go Radial, the AHA Offers Some Insights

L.A. McKeown

December 12, 2024

News Daily News

Could Pricey GLP-1 Drugs Cut Healthcare Costs? The Math Isn’t Simple

L.A. McKeown

December 09, 2024

News Daily News

Rethinking the Evidence for ICDs for HFrEF in Light of Today’s GDMT

L.A. McKeown

December 05, 2024

News Daily News

IVC Filter Lawsuits Expose Holes in FDA Oversight and Public Communication

L.A. McKeown

December 03, 2024

News Daily News

ZENITH: Novel Biologic Reduces Morbidity and Mortality in PAH

L.A. McKeown

November 26, 2024

News Opinion CV Team Dispatch

November 2024 Dispatch for the CV Team

L.A. McKeown

November 26, 2024

News Conference News AHA 2024

REALIZE-K: Potassium Binder Boosts MRA Use in Hyperkalemic HFrEF Patients

L.A. McKeown

November 22, 2024

News Conference News VIVA 2024

DETOUR 2: Endovascular Procedure That Mimics Femoral Bypass Durable at 3 Years

L.A. McKeown

November 11, 2024

News Conference News VIVA 2024

Advocates Urge Heat Maps and Grassroots Campaigns to Improve PAD Care

L.A. McKeown

November 07, 2024

News Conference News VIVA 2024

Amputations Still Avoided With Flow-Diverting Therapy for CLTI at 2 Years: PROMISE II

L.A. McKeown

November 06, 2024

News Conference News VIVA 2024

Disappearing Scaffold for CLTI Still Works Well at 2 Years: LIFE-BTK

L.A. McKeown

November 05, 2024

News Conference News TCT 2024

Pooled All-Female Analysis Support Benefits of TAVI Over SAVR

L.A. McKeown

November 01, 2024

News Conference News TCT 2024

SIRONA: Sirolimus and Paclitaxel DCBs Offer Similar Patency, Function in PAD

L.A. McKeown

October 29, 2024

Advertisement

Study Links Osteoporosis Injections and Increased MACE in Dialysis Patients

Top Structural Heart News of 2024

Top Endovascular News of 2024

Tirzepatide Gets FDA Approval for Sleep Apnea in Adults With Obesity

December 2024 Dispatch for the CV Team

Obesity Trends May Be Going in the Right Direction for the First Time in a Decade

FINEARTS-HF Analysis Supports Finerenone’s Value in HFpEF With Obesity

As More Peripheral Interventions Go Radial, the AHA Offers Some Insights

Could Pricey GLP-1 Drugs Cut Healthcare Costs? The Math Isn’t Simple

Rethinking the Evidence for ICDs for HFrEF in Light of Today’s GDMT

IVC Filter Lawsuits Expose Holes in FDA Oversight and Public Communication

ZENITH: Novel Biologic Reduces Morbidity and Mortality in PAH

November 2024 Dispatch for the CV Team

REALIZE-K: Potassium Binder Boosts MRA Use in Hyperkalemic HFrEF Patients

DETOUR 2: Endovascular Procedure That Mimics Femoral Bypass Durable at 3 Years

Advocates Urge Heat Maps and Grassroots Campaigns to Improve PAD Care

Amputations Still Avoided With Flow-Diverting Therapy for CLTI at 2 Years: PROMISE II

Disappearing Scaffold for CLTI Still Works Well at 2 Years: LIFE-BTK

Pooled All-Female Analysis Support Benefits of TAVI Over SAVR

SIRONA: Sirolimus and Paclitaxel DCBs Offer Similar Patency, Function in PAD

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content